Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

828 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO.
Pivot X, Schneeweiss A, Verma S, Thomssen C, Passos-Coelho JL, Benedetti G, Ciruelos E, von Moos R, Chang HT, Duenne AA, Miles DW. Pivot X, et al. Eur J Cancer. 2011 Nov;47(16):2387-95. doi: 10.1016/j.ejca.2011.06.018. Epub 2011 Jul 15. Eur J Cancer. 2011. PMID: 21757334 Clinical Trial.
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.
Miles DW, Chan A, Dirix LY, Cortés J, Pivot X, Tomczak P, Delozier T, Sohn JH, Provencher L, Puglisi F, Harbeck N, Steger GG, Schneeweiss A, Wardley AM, Chlistalla A, Romieu G. Miles DW, et al. J Clin Oncol. 2010 Jul 10;28(20):3239-47. doi: 10.1200/JCO.2008.21.6457. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498403 Clinical Trial.
13. New biological therapies for breast cancer.
Plunkett TA, Miles DW. Plunkett TA, et al. Among authors: miles dw. Int J Clin Pract. 2002 May;56(4):261-6. Int J Clin Pract. 2002. PMID: 12074208 Review.
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer.
Buzdar AU, Xu B, Digumarti R, Goedhals L, Hu X, Semiglazov V, Cheporov S, Gotovkin E, Hoersch S, Rittweger K, Miles DW, O'Shaughnessy J, Tjulandin S; NO16853 trial group. Buzdar AU, et al. Among authors: miles dw. Ann Oncol. 2012 Mar;23(3):589-597. doi: 10.1093/annonc/mdr256. Epub 2011 Jun 1. Ann Oncol. 2012. PMID: 21633047 Clinical Trial.
Mucin based breast cancer vaccines.
Miles DW, Taylor-Papadimitriou J. Miles DW, et al. Expert Opin Investig Drugs. 1998 Nov;7(11):1865-77. doi: 10.1517/13543784.7.11.1865. Expert Opin Investig Drugs. 1998. PMID: 15991935
828 results